Skip Navigation Archive: U.S. Department of Health and Human Services U.S. Department of Health and Human Services
Archive: Agency for Healthcare Research Quality www.ahrq.gov
Archival print banner

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to www.ahrq.gov for current information.

Cellulitis and Abscess Management in the Era of Resistance to Antibiotics (CAMERA)

Appendix F. Chart Audit Instrument

I. Patient Demographic Information

  1. Age (years): _________ (if <1, Enter 0)
  2. Gender

    __ 1 Male
    __ 2 Female

  3. Race(check all that apply)
     

    __ 1 American Indian / Alaska Native
    __ 2 Asian
    __ 3 Native Hawaiian or Other Pacific Islander
    __ 4 Black or African American
    __ 5 White
    __ 6 Unknown

  1. Ethnicity

    __ 1 Hispanic or Latino
    __ 2 Not Hispanic or Latino
    __ 3 Unknown

  2. Insurance Status (check all that apply)

    __ 1 Private or Managed Care
    __ 2 Medicare
    __ 3 Medicaid
    __ 4 No Insurance / Self Pay
    __ 5 Unknown

II. Visit Information — Reason for Visit:

  1. Visit Date (MM/YYYY): ___ ___/20___ ___
  2. Documented Risk Factors

    (check all that apply)
    __ 1 Recent hospitalization (within 1 month)
    __ 2 Family member within (last 6 months)
    __ 3 Sport team: ____________________________
    __ 4 History of MRSA: __________________
    __ 5 Eczema
    __ 6Other skin condition: ______________________
    __ 7 Immunocompromized
          (Cancer, HIV, chronic oral steroid use, or
           described as immunocompromized)

    __ 8 Diabetes
    __ 9 None

  3. Fever:

    a. History of fever: __ 1 Yes  __ 0 No

          b. Visit temperature ______°   __ 1 C   __ 2 F

  4. Number of skin or soft tissue lesions: ______

    a. Describe if no number given.

  5. Description of the largest lesion:
     

    a. Location: _________________
    (face, neck, trunk, arm, hand, buttock, leg, foot, head, elsewhere)

  1. Description of largest site continued:

    b. Size:
       __ 1 < 1 cm
       __ 2 1-5 cm
       __ 3 > 5 cm
       __ 4 Unknown/not documented in chart

      Yes No No Mention
    c. Red (erythema) 1 0 7
    d. Swollen (edema) 1 0 7
    e. Warm 1 0 7
    f. Painful/Tender 1 0 7
    g. Fluctuant, yellow or white center, central point or “head” (induration) 1 0 7
    h. Draining Pus (discharge, purulent) 1 0 7
  2. Incision and Drainage(check all that apply)

    __ 1 Incision and Drainage
    __ 2 Needle Aspiration
    __ 3 Referred
    __ 4 Manually Expressed
    __ 5 Packed
    __ 6 Not performed

III. Treatment and Follow-up

  1. Culture —review the chart for:

    __ 1 Obtained
    __ 0 Not Obtained

  2. If culture was obtained, which of the following was documented (Check all that apply)

    __ 1 Final Culture Result:_________________
    __ 2 Patient Notification
    __ 3 New Prescription, specifiy:________________
    __ 0 Not documented in chart

  3. Antibiotic Initially Prescribed: __ 1 Yes↓  __ 0 No

         1a. If Yes, name(s): _________________________

  1. Initial Antibiotic justification:

    __ 1 Empiric for suspected MRSA
    __ 2 Empiric for non-MRSA or Streptococcus
    __ 3 Other, specify:  _______________________
    __ 0 None

  2. Scheduled patient follow-up

    __ 1 PRN (as needed)
    __ 2 Return to clinic scheduled
    __ 0 None

  3. Patient education (Check all that apply)

    __ 1 Documented reasons to follow-up
    __ 2 Patient hand-out
    __ 3 Verbal teaching
    __ 0 None

IV. Diagnoses and Billing Codes

1. All ICD-9 Codes for the Visit:

a. ___________

b. ___________

c. ___________

d. ___________

e. ___________

2. All CPT Codes for the Visit:

a. ___________

b. ___________

c. ___________

d. ___________

e. ___________

V. Subsequent Office Care (next 14 days) and Patient Outcomes

A. Subsequent Office Care:

  1. Number of return office visits for the same infection(s): _______
  2. Any additional procedures in the office:
  3. If YES, complete section VI

    ←      __ 1 Yes↓  __ 0 No

  4. Change in Antibiotic:       __ 1 Yes   __ 0 No      3a. If Yes, name(s):_________________________
  5. Emergency department / urgent care visit:
     

    __ 1 Yes  __ 0 No

  6. Hospitalization: __ 1 Yes  __ 0 No

B. Patient-reported Outcomes:

  1. Type of report:      __ 1 Diary
                                    __ 2 Telephone Survey
      __ 0 None → (STOP, end of audit)
  2. Number of days until resolution of fever:      ____
  3. Number of days until resolution of infection: ____
  4. Reported antibiotic change:    __ 1 Yes↓  __ 0 No

         4a. If Yes, name(s):_________________________

  5. Reported Emergency Department Visit:     
    __ 1 Yes  __ 0 No
  6. Reported Hospitalization:    __ 1 Yes  __ 0 No

VI. Subsequent Visit Information (only answer the following sections if question V.A2. is “YES”)

  1. Visit Date (MM/YYYY): ___ ___/20___ ___
  2. Documented Risk Factors

    (check all that apply)
    __ 1 Recent hospitalization (within 1 month)
    __ 2 Family member within (last 6 months)
    __ 3 Sport team: ____________________________
    __ 4 History of MRSA: __________________
    __ 5 Eczema
    __ 6Other skin condition: ______________________
    __ 7 Immunocompromized
          (Cancer, HIV, chronic oral steroid use, or
           described as immunocompromized)

    __ 8 Diabetes
    __ 9 None

  3. Fever: 

    a. History of fever: __ 1 Yes  __ 0 No

          b. Visit temperature ______°   __ 1 C   __ 2 F

  4. Number of skin or soft tissue lesions: ______
  5. Description of the largest lesion:

    a. Location: _________________
    (face, neck, trunk, arm, hand, buttock, leg, foot, head, elsewhere)

  1. Description of largest site continued:

    b. Size:
       __ 1 < 1 cm
       __ 2 1-5 cm
       __ 3 > 5 cm  
       __ 4 Unknown/not documented in chart

      Yes No No Mention
    c. Red (erythema) 1 0 7
    d. Swollen (edema) 1 0 7
    e. Warm 1 0 7
    f. Painful/Tender 1 0 7
    g. Fluctuant, yellow or white center, central point or “head” (induration) 1 0 7
    h. Draining Pus (discharge, purulent) 1 0 7
  2. Incision and Drainage(check all that apply)

    __ 1 Incision and Drainage
    __ 2 Needle Aspiration
    __ 3 Referred
    __ 4 Manually Expressed
    __ 5 Packed
    __ 6 Not performed

VII. Subsequent Treatment and Follow-up

  1. Culture —review the chart for:

    __ 1 Obtained
    __ 0 Not Obtained

  2. If culture was obtained, which of the following was documented (Check all that apply)

    __ 1 Final Culture Result:_________________
    __ 2 Patient Notification
    __ 3 New Prescription, specifiy:________________
    __ 0 Not documented in chart

  3. Antibiotic Prescribed: __ 1 Yes  __ 0 No      1a. If Yes, name(s):_________________________
  1. Antibiotic justification:

    __ 1 Empiric for suspected MRSA
    __ 2 Empiric for non-MRSA or Streptococcus
    __ 3 Other, specify:_______________________
    __ 0 None

  2. Scheduled patient follow-up

    __ 1 PRN (as needed)
    __ 2 Return to clinic scheduled
    __ 0 None

  3. Patient education (Check all that apply)

    __ 1 Documented reasons to follow-up
    __ 2 Patient hand-out
    __ 3 Verbal teaching
    __ 0 None

VIII. Subsequent Diagnoses and Billing Codes

1. All ICD-9 Codes for the Visit:

a. ___________

b. ___________

c. ___________

d. ___________

e. ___________

2. All CPT Codes for the Visit:

a. ___________

b. ___________

c. ___________

d. ___________

e. ___________

Return to Contents

Page last reviewed October 2014
Page originally created September 2012
Internet Citation: Appendix F. Chart Audit Instrument. Content last reviewed October 2014. Agency for Healthcare Research and Quality, Rockville, MD. https://archive.ahrq.gov/research/findings/final-reports/mrsa/nc_mrsaapf.html

The information on this page is archived and provided for reference purposes only.

 

AHRQ Advancing Excellence in Health Care